SCHEMBL25546197

SCHEMBL25546197

N#Cc1ccc(-c2ccc(N(c3ccc(Br)cc3)c3ccc(Br)cc3)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 2/20 0.52
▸ MAOA P21397 1/20 0.52
▸ MMP3 P08254 1/20 0.47
▸ CYP19A1 P11511 1/20 0.45
▸ KIF11 P52732 3/20 0.42
▸ AHR P35869 2/20 0.41
▸ CA12 O43570 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ CA9 Q16790 1/20 0.40
▸ IDO1 P14902 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CYP11B2 P19099 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CYP2A6 P11509 2/20 0.38
▸ HDAC2 Q92769 1/20 0.38
▸ ENPP2 Q13822 1/20 0.38
▸ ERBB2 P04626 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26965567 0.94 MAOB (0.57) MAOBMAOAMMP3CYP19A1AHR
SCHEMBL16282335 0.93 ALDH1A1 (0.52) MAOBMAOAMMP3CYP19A1KIF11
SCHEMBL15683760 0.93 ALDH1A1 (0.52) MAOBMAOAMMP3CYP19A1KIF11
SCHEMBL16282333 0.93 ALDH1A1 (0.52) MAOBMAOAMMP3CYP19A1KIF11
SCHEMBL25544161 0.89 MMP3 (0.56) MMP3KIF11CA12CA1CA2
SCHEMBL25543233 0.89 MMP3 (0.56) MMP3KIF11CA12CA1CA2
SCHEMBL1773406 0.87 MAOB (0.64) MAOBMAOAMMP3KIF11AHR
SCHEMBL15496905 0.87 MAOB (0.64) MAOBMAOAMMP3KIF11AHR
SCHEMBL16282343 0.87 MAOB (0.41) MAOBMAOAMMP3CYP19A1KIF11
SCHEMBL16283900 0.87 MAOB (0.41) MAOBMAOAMMP3CYP19A1KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 — — US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 — — US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 MAOB 92/4885MAOA 38/4885MMP3 4768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback